9 trends tracked about this subject — the full history, oldest to newest below.
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
Ozempic’s “temporal hollowing” side effect is sparking a surge in cosmetic procedures, prompting medical warnings.
Health experts and trainers are advocating for targeted strength training for adults over 50 to combat age-related muscle loss and improve longevity.
Reports link Ozempic and similar GLP‑1 drugs to altered smell and taste, sparking a new “Ozempic mouth” discussion
GLP-1 drugs like Ozempic may offer an unexpected fertility boost for obese men, reshaping reproductive health approaches
New clinical research presented at ASCO26 suggests a potential link between GLP-1 receptor agonist medications and reduced cancer risk.
New research indicates that patients taking GLP-1 weight loss drugs are reducing their physical activity levels.
GLP-1 weight-loss drugs are exposing a hidden health crisis: nutrient deficiencies linked to rapid weight loss
US employers may halt GLP-1 drug coverage in 2027 amid rising costs and usage spikes